160 related articles for article (PubMed ID: 17464317)
41. Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney.
Argani P; Faria PA; Epstein JI; Reuter VE; Perlman EJ; Beckwith JB; Ladanyi M
Am J Surg Pathol; 2000 Aug; 24(8):1087-96. PubMed ID: 10935649
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of bcl-2 protein in synovial sarcoma: a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization.
Hirakawa N; Naka T; Yamamoto I; Fukuda T; Tsuneyoshi M
Hum Pathol; 1996 Oct; 27(10):1060-5. PubMed ID: 8892591
[TBL] [Abstract][Full Text] [Related]
43. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma.
Tanaka S; Tajiri T; Noguchi S; Shono K; Ihara K; Hara T; Suita S
J Pediatr Surg; 2004 Jan; 39(1):63-8. PubMed ID: 14694373
[TBL] [Abstract][Full Text] [Related]
44. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Matono H; Iwamoto Y; Taguchi T; Tsuneyoshi M
Mod Pathol; 2010 Jul; 23(7):981-90. PubMed ID: 20305614
[TBL] [Abstract][Full Text] [Related]
45. A reverse transcriptase-polymerase chain reaction assay in the diagnosis of soft tissue sarcomas.
Naito N; Kawai A; Ouchida M; Dan'ura T; Morimoto Y; Ozaki T; Shimizu K; Inoue H
Cancer; 2000 Nov; 89(9):1992-8. PubMed ID: 11064357
[TBL] [Abstract][Full Text] [Related]
46. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.
Wei Y; Wang J; Zhu X; Shi D; Hisaoka M; Hashimoto H
Chin Med J (Engl); 2002 Jul; 115(7):1043-7. PubMed ID: 12150740
[TBL] [Abstract][Full Text] [Related]
47. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value.
Vandesompele J; Edsjö A; De Preter K; Axelson H; Speleman F; Påhlman S
Oncogene; 2003 Jan; 22(3):456-60. PubMed ID: 12545167
[TBL] [Abstract][Full Text] [Related]
48. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
[TBL] [Abstract][Full Text] [Related]
49. Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.
Schaub R; Burger A; Bausch D; Niggli FK; Schäfer BW; Betts DR
Cancer Genet Cytogenet; 2007 Jan; 172(1):61-5. PubMed ID: 17175381
[TBL] [Abstract][Full Text] [Related]
50. [Molecular diagnosis of synovial sarcoma].
Martegani MP; Gasbarri A; Bartolazzi A; Ruco L
Pathologica; 2002 Oct; 94(5):257-62. PubMed ID: 12420613
[No Abstract] [Full Text] [Related]
51. Detection of SYT and EWS gene rearrangements by dual-color break-apart CISH in liquid-based cytology samples of synovial sarcoma and Ewing sarcoma/primitive neuroectodermal tumor.
Kumagai A; Motoi T; Tsuji K; Imamura T; Fukusato T
Am J Clin Pathol; 2010 Aug; 134(2):323-31. PubMed ID: 20660338
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
Hung YP; Fletcher CD; Hornick JL
Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
[TBL] [Abstract][Full Text] [Related]
53. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
54. Biphasic synovial sarcoma of the peritoneal cavity with t(X;18) demonstrated by reverse transcriptase polymerase chain reaction.
Kashima T; Matsushita H; Kuroda M; Takeuchi H; Udagawa H; Ishida T; Hara M; Machinami R
Pathol Int; 1997 Sep; 47(9):637-41. PubMed ID: 9311017
[TBL] [Abstract][Full Text] [Related]
55. Investigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomas.
de Souza RR; Oliveira ID; del Giúdice Paniago M; Yaoita FH; Caran EM; Macedo CR; Petrilli AS; Abib Sde C; de Seixas Alves MT; de Toledo SR
Growth Horm IGF Res; 2014 Aug; 24(4):130-6. PubMed ID: 24846856
[TBL] [Abstract][Full Text] [Related]
56. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma.
Valente AL; Tull J; Zhang S
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007
[TBL] [Abstract][Full Text] [Related]
57. [Detection of SYT-SSX fusion gene in paraffin-embedded tissues and its clinicopathologic significance for synovial sarcoma].
Wei Y; Sun M; Zhu H; Xu Z; Wang J; Zhu X
Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):426-30. PubMed ID: 11866984
[TBL] [Abstract][Full Text] [Related]
58. Primary monophasic synovial sarcoma of the duodenum with SYT/SSX2 type of translocation.
Schreiber-Facklam H; Bode-Lesniewska B; Frigerio S; Flury R
Hum Pathol; 2007 Jun; 38(6):946-9. PubMed ID: 17509396
[TBL] [Abstract][Full Text] [Related]
59. Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification.
Valentijn LJ; Koster J; Haneveld F; Aissa RA; van Sluis P; Broekmans ME; Molenaar JJ; van Nes J; Versteeg R
Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19190-5. PubMed ID: 23091029
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.
Zhou Y; Chen D; Qi Y; Liu R; Li S; Zou H; Lan J; Ju X; Jiang J; Liang W; Shen Y; Pang L; Li F
Oncol Rep; 2017 Jun; 37(6):3351-3360. PubMed ID: 28498445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
